azenta (nasdaq: azta) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. azenta is headquartered in chelmsford, ma, with operations in north america, europe and asia. for more information, please visit www.azenta.com.
Company profile
Ticker
AZTA
Exchange
Website
CEO
Stephen Schwartz
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
BROOKS AUTOMATION INC, Brooks Automation, Inc., BROOKS-PRI AUTOMATION INC
SEC CIK
Corporate docs
Subsidiaries
Abeyatech LLC • Azenta Beijing Technologies Limited • Azenta (Guangzhou) Life Science Co., Ltd. • Azenta Germany GmbH • Azenta Japan Corp. • Azenta Life Sciences Canada, Inc. • Azenta Luxembourg SARL • Azenta (Nanjing) Life Science Technologies Co., Ltd. • Azenta Switzerland AG • Azenta (Shanghai) Life Science Co. Ltd. ...
IRS number
43040660
AZTA stock data
Latest filings (excl ownership)
8-K
Regulation FD Disclosure
14 Mar 24
10-Q
2024 Q1
Quarterly report
8 Feb 24
8-K
Results of Operations and Financial Condition
7 Feb 24
8-K
Submission of Matters to a Vote of Security Holders
1 Feb 24
8-K
Regulation FD Disclosure
31 Jan 24
DEFA14A
Additional proxy soliciting materials
17 Jan 24
8-K
Departure of Directors or Certain Officers
17 Jan 24
DEFA14A
Additional proxy soliciting materials
11 Jan 24
ARS
2023 FY
Annual report to shareholders
15 Dec 23
DEFA14A
Additional proxy soliciting materials
15 Dec 23
Transcripts
AZTA
Earnings call transcript
2024 Q1
7 Feb 24
AZTA
Earnings call transcript
2023 Q4
13 Nov 23
AZTA
Earnings call transcript
2023 Q2
8 Aug 23
AZTA
Earnings call transcript
2023 Q2
9 May 23
AZTA
Earnings call transcript
2023 Q1
8 Feb 23
AZTA
Earnings call transcript
2022 Q4
15 Nov 22
AZTA
Earnings call transcript
2022 Q3
10 Aug 22
AZTA
Earnings call transcript
2022 Q2
9 May 22
AZTA
Earnings call transcript
2022 Q1
9 Feb 22
AZTA
Earnings call transcript
2021 Q4
11 Nov 21
Latest ownership filings
4
Jason Joseph
2 Apr 24
144
Notice of proposed sale of securities
1 Apr 24
4
Jason Joseph
11 Mar 24
144
Notice of proposed sale of securities
8 Mar 24
144
Notice of proposed sale of securities
7 Mar 24
144
Notice of proposed sale of securities
14 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
4
Robyn C Davis
13 Feb 24
4
Michael Rosenblatt
13 Feb 24
4
Martin D Madaus
13 Feb 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Sep 23 | Sep 22 | Sep 21 | Sep 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 684.05 mm | 684.05 mm | 684.05 mm | 684.05 mm | 684.05 mm | 684.05 mm |
Cash burn (monthly) | 17.37 mm | 29.77 mm | 5.54 mm | 6.09 mm | (no burn) | (no burn) |
Cash used (since last report) | 118.32 mm | 202.78 mm | 37.75 mm | 41.51 mm | n/a | n/a |
Cash remaining | 565.72 mm | 481.27 mm | 646.29 mm | 642.54 mm | n/a | n/a |
Runway (months of cash) | 32.6 | 16.2 | 116.6 | 105.4 | n/a | n/a |
Institutional ownership, Q3 2023
13F holders | Current |
---|---|
Total holders | 300 |
Opened positions | 39 |
Closed positions | 37 |
Increased positions | 69 |
Reduced positions | 142 |
13F shares | Current |
---|---|
Total value | 2.95 tn |
Total shares | 58.99 mm |
Total puts | 67.40 k |
Total calls | 188.20 k |
Total put/call ratio | 0.4 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 6.04 mm | $303.15 bn |
BLK Blackrock | 5.57 mm | $279.36 bn |
Kayne Anderson Rudnick Investment Management | 4.53 mm | $227.45 bn |
Politan Capital Management | 4.52 mm | $226.81 bn |
Allspring Global Investments | 1.82 mm | $91.31 bn |
STT State Street | 1.79 mm | $89.66 bn |
Dimensional Fund Advisors | 1.70 mm | $85.39 bn |
GW&K Investment Management | 1.61 mm | $80.79 bn |
Teacher Retirement System Of Texas | 1.15 mm | $57.58 bn |
Conestoga Capital Advisors | 1.14 mm | $57.18 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Apr 24 | Joseph Jason | Common Stock | Sale back to company | Dispose D | No | Yes | 60.15 | 1,000 | 60.15 k | 93,006 |
8 Mar 24 | Joseph Jason | Common Stock | Sale back to company | Dispose D | No | Yes | 67.5 | 4,000 | 270.00 k | 94,006 |
7 Mar 24 | Joseph Jason | Common Stock | Sale back to company | Dispose D | No | Yes | 65 | 4,000 | 260.00 k | 98,006 |
7 Mar 24 | Joseph Jason | Common Stock | Sale back to company | Dispose D | No | Yes | 65.2 | 4,000 | 260.80 k | 102,006 |
7 Mar 24 | Joseph Jason | Common Stock | Sale back to company | Dispose D | No | Yes | 65.21 | 1,000 | 65.21 k | 106,006 |
31 Jan 24 | Violetta Hughes | Common Stock | Grant | Dispose A | No | No | 65.2 | 311 | 20.28 k | 3,746 |
5 Dec 23 | Robin Vacha | Common Stock | Sale back to company | Dispose D | No | No | 56.6 | 5,175 | 292.91 k | 25,788 |
1 Dec 23 | David Dong Wang | Common Stock | Sale back to company | Dispose D | No | No | 57.96 | 138 | 8.00 k | 9,478 |
News
Needham Maintains Buy on Azenta, Maintains $75 Price Target
8 Apr 24
Evercore ISI Group Maintains In-Line on Azenta, Lowers Price Target to $60
4 Apr 24
Jefferies Initiates Coverage On Azenta with Hold Rating, Announces Price Target of $64
4 Apr 24
Decoding 7 Analyst Evaluations For Azenta
28 Mar 24
Needham Reiterates Buy on Azenta, Maintains $75 Price Target
28 Mar 24
Press releases
Azenta Publishes its 2023 Environmental, Social, & Governance (ESG) Report
1 Apr 24
Azenta to Participate in the 23rd Annual Needham Virtual Healthcare Conference
1 Apr 24
Azenta to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum
12 Mar 24
Azenta Reports First Quarter Results for Fiscal 2024, Ended December 31, 2023
7 Feb 24
Azenta Launches the BioArc™ Ultra, a Breakthrough, Automated Solution for Efficient, Eco-Friendly Ultracold Sample Management
2 Feb 24